PUBLIC CONTRACT · 2019
41031519 - Aq urgente medicamentos
- Contract value
- €28,565.62
- Signed on
- 1 October 2019
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5913759PUBLISHED SUBJECT
Nintedanib 150 mg Cáps Vedolizumab 300 mg Pó conc sol inj Fr IV Lenalidomida 5 mg Cáps Pomalidomida 4 mg Cáps
Parties involved
- Place of performance
- Portugal, Setúbal, Setúbal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- CELGENE PORTUGAL · Tax ID 507791690
- Awardee
- TAKEDA · Tax ID 502801204
Values and timeline
- Contract price
- €28,565.62
- Procedure base price
- €28,565.62
- Total effective price
- Not reported on Portal BASE
- Publication date
- 9 October 2019
- Award date
- 1 October 2019
- Signing date
- 1 October 2019
- Performance period
- 10 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4201821
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.